A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)

Clinical trial NCT05442775 · TERMINATED

Trial details

NCT number: NCT05442775
Sponsor: Cytokinetics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2022-08-04
Primary completion: 2023-06-07
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.